Digenes Akritas is an epic poem from the Byzantine Empire. It follows the exploits of the titular hero in the Byzantine ...

Agios Pharmaceuticals (AGIO) announced that the ACTIVATE-Kids Phase 3 study of mitapivat in children aged 1 to less than18 years with PK deficiency who are not regularly transfused achieved its ...

In a report released yesterday, Gregory Renza from RBC Capital maintained a Buy rating on Agios Pharma (AGIO – Research Report), with a price target of $57.00. The company’s shares closed ...

Icon Energy Corp. ATHENS, Greece, Jan. 23, 2025 (GLOBE NEWSWIRE) -- Icon Energy Corp. (“Icon” or the “Company”) (Nasdaq: ICON), an international shipping company that provides worldwide ...

Agios Pharmaceuticals' focus is on expanding Pyrukund's label to treat thalassemia and sickle cell disease, targeting multi-billion dollar markets. Despite promising Phase 3 results, safety ...

Agios' ACTIVATE-Kids trial showed 31.6% of mitapivat-treated children met the hemoglobin response endpoint vs. 0% in the placebo group. Agios reported Q4 Pyrukynd revenue of $10.7M, exceeding the ...

In this article, we are going to take a look at where Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) stands against the other cheap biotech stocks. Biotechnology stocks are among the most volatile in ...

GALVESTON COUNTY, Texas (KTRK) -- Dimitrios Pagourtzis, the student accused of the deadly 2018 shooting at Santa Fe High School, has been re-committed to a hospital maximum security unit for ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Dimitrios Pagourtzis, the Santa Fe High School student accused of killing 10 people in a May 18, 2018, shooting at the high school, is escorted by Galveston County Sheriff’s Office deputies into ...